Menu

Latest news & events

Fellowships EmbRACE consortium

Fellowships EmbRACE consortium

21 May 2026

The EmbRACE consortium, coordinated by CARIM, has awarded three fellowships, including two to CARIM researchers.

Read more
NWO grant for project 'Laminomics'

NWO grant for project 'Laminomics'

21 May 2026

Tim van de Wiel, Dr Magdalena Harakalova, and Dr Rogier Veltrop (Dept of Biochemistry) have been awarded an NWO grant for large-scale high-performance computing time.

Read more
More newsMore events
Carim Maastricht
Carim Maastricht

Stephane Heymans

Professor

Stephane Heymans is Professor of Cardiomyopathies and Head of the Centre for Heart Failure Research, Department of Cardiology, Maastricht University. He obtained his Medical Degree from the KU Leuven (Belgium) in 1995 and went on to get a PhD in Medical Sciences in 2000, studying the role of proteinases in acute myocardial infarction. In 2003, he joined the Department of Cardiology of Maastricht UMC+ as an academic medical specialist and in 2006 he took over the Multidisciplinary Cardiomyopathy Program (Genetics, Immunology, Microbiology and Pathology departments).

In 2008, he established his independent research laboratory at Cardiovascular Research Institute Maastricht. His research interests focus on the molecular mechanisms of heart failure, looking at the interplay between inflammatory cells, fibroblasts and cardiomyocytes. Particular focus is on the role of non-structural matrix proteins, matrix turnover and non-coding RNAs.

Furthermore, he is Professor of 'Inflammation and Matrix Biology in Cardiomyopathies' at the University of Leuven and he is a board member of the ESC Heart Failure Association, ESC Working Group of Myocardial Function, ESC Heart Failure Association Committee on Diastolic Heart Failure and ESC Heart Failure Association Committee on Translational Research.

Website www.hfresearch.eu

Stephane-heymans

Department of Cardiology
Universiteitssingel 50, 6229 ER Maastricht
PO Box 616, 6200 MD Maastricht
Room number: G3.230
T: +31(0)43 388 43 04

  • 2026
    • Bianchi, L., Afonso, L., Chendey, T., Modumudi, S., Minghini, A., Verdonschot, J. A. J., & Heymans, S. R. B. (2026). Efficacy and safety of sodium-glucose cotransporter inhibitors in hypertrophic cardiomyopathy: a systematic review. IJC Heart and Vasculature, 64, Article 101906. https://doi.org/10.1016/j.ijcha.2026.101906
    • de Gonzalo-Calvo, D., García-Hidalgo, M. C., Chatterjee, S., Thum, S., Ferreira, J. P., Rossignol, P., Girerd, N., Verdonschot, J. A. J., Heymans, S., Staessen, J. A., Cleland, J. G. F., Zannad, F., Thum, T., & Bär, C. (2026). Mechanistic insights into heart failure progression and therapeutic target discovery through plasma microRNA profiling: Findings from HOMAGE. European journal of internal medicine, 147, Article 106724. https://doi.org/10.1016/j.ejim.2026.106724
    • Deissler, P. M., Rahm, A. K., Berkovitch, A., Müller, M. E., Sikking, M., Heymans, S., Langenberg, B., Moersdorf, M., Rieder, M., Nimani, S., Odening, K. E., Dichtl, W., Sabbag, A., Volders, P. G. A., & Ter Bekke, R. M. A. (2026). Temporal variability of the electromechanical window in long-QT syndrome and drug-induced QT prolongation: Value for enhanced arrhythmia-risk assessment. Heart Rhythm, 23(4), e636-e646. https://doi.org/10.1016/j.hrthm.2026.01.013
    • Verdonschot, J. A. J., Van Spaendonck-Zwarts, K. Y., Hellebrekers, D. M. E., Asselbergs, F. W., Behr, E. R., Charron, P., Dawson, D., Garcia-Pavia, P., Haugaa, K. H., Jurcut, R., Kuchynka, P., Lopes, L. R., Mazzanti, A., Metra, M., Monserrat, L., Kaski, J. P., Pantazis, A., Prasad, S. K., Rosano, G., ... Van Tintelen, J. P. (2026). Genetic counselling implementation in dilated cardiomyopathy. European Heart Journal. Advance online publication. https://doi.org/10.1093/eurheartj/ehag159
    • Ravassa, S., Girerd, N., Edelman, F., Lopez, B., Ferreira, J. P., Zurkan, D., Jose, G. S., Latasa, I., Pellicori, P., Cosmi, F., Petutschnigg, J., Heymans, S., Brunner-La Rocca, H.-P., Pieske, B., Delles, C., Clark, A. L., Diez, J., Zannad, F., Cleland, J. G. F., ... HOMAGE Trial Committees and Investigators (2026). Spironolactone and Fibrosis in Heart Failure Risk: Machine Learning Analysis of HOMAGE Trial Plasma Proteomics. MedComm, 7(3), Article e70634. https://doi.org/10.1002/mco2.70634
    • Torfs, T., Veltrop, R. J. A., Lezzoche, G., Heymans, S. R. B., Verdonschot, J. A. J., & Nabben, M. (2026). Metabolic Dysregulation in Laminopathies: Implications for Heart Failure and Cardiac Health. Current Heart Failure Reports, 23(1), Article 6. https://doi.org/10.1007/s11897-025-00735-8
    • Raafs, A. G., Verdonschot, J. A. J., Knackstedt, C., Nijveldt, R., & Heymans, S. R. B. (2026). Clinical and prognostic impact of left atrial strain in non-ischemic cardiomyopathies. International Journal of Cardiovascular Imaging, 42(2), 175-193. https://doi.org/10.1007/s10554-025-03597-2
    • Heymans, A. B. M., van de Leur, R. R., Wang, P., González-López, E., Venner, M. F. G. H. M., Beelen, N. J., Muller, S. A., Mora-Ayestarán, N., Ramos, N., Faassen, I. M. E., Stroeks, S. L. V. M., Soria, M., van der Crabben, S. N., ter Bekke, R. M. A., van Es, R., Vernooy, K., te Riele, A. S. J. M., García-Pavía, P., Heymans, S. R. B., & Verdonschot, J. A. J. (2026). Detection of Titin-Associated Electrocardiography Features in Dilated Cardiomyopathy Using Conventional and Deep Neural Network Analysis. JACC: Clinical Electrophysiology, 12(2), 363-374. https://doi.org/10.1016/j.jacep.2025.10.006
    • Peretto, G., Merlo, M., Ambrosi, A., Bacigalupi, E., Villatore, A., Molinari, L., Anguera, I., Claver, E., Dal Ferro, M., Suwalski, P., Spartalis, M., Verdonschot, J., Ciabatti, M., Martini, N., Zampieri, M., Paldino, A., Valeri, Y., Radesich, C., Lazzeroni, D., ... Sinagra, G. (2026). Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score. European Heart Journal, 47(1), 94-106. Article ehaf477. https://doi.org/10.1093/eurheartj/ehaf477
  • 2025
    • Johnson, R., Fletcher, R. A., Peters, S., Ohanian, M., Soka, M., Smolnikov, A., Abihider, K. E., Ackerman, M. J., Ader, F., Akhtar, M. M., Amin, A. S., Ashley, E. A., Atherton, J. J., Austin, R., Baas, A. F., Bagnall, R. D., Ross, S. B., Blouin, J.-L., Brown, E. E., ... Australian Genomics Cardiac Flagship (2025). Titin-related familial dilated cardiomyopathy: factors associated with disease onset. European Heart Journal, 46(48), 5240-5257. https://doi.org/10.1093/eurheartj/ehaf380
Overview